Biogen Idec Inc $335.45

down -1.34


25/7/2014 04:00 PM  |  NASDAQ : BIIB  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get BIIB Trend Analysis - it has outperformed the S&P 500 by 31%

Partner Headlines

  1. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  2. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  3. Biogen, Gilead Profits Soar

    IBD
  4. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  5. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD
  6. IPO Stock Watch: Biotechs Are Half Of July Calendar

    IBD
  7. Vertex Is Poised For An Earnings Breakout

    Benzinga
  8. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout ...

    Benzinga
  9. S&P 500 Flirts With High; Breadth Missing On Nasdaq

    IBD
  10. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga
  11. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  12. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  13. Apple, Microsoft Lead Nasdaq Higher; Dow Falters

    IBD
  14. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga
  15. Stocks: Mixed Open, Mixed Trade; Delta, Broadcom, Biogen Buck Up

    IBD
  16. Morning Market Movers

    Benzinga
  17. UPDATE: Biogen Idec Posts Stronger-Than-Expected Q2 Results, Shares Surge

    Benzinga
  18. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. Earnings Scheduled For July 23, 2014

    Benzinga
  21. Stocks Rise; Apple, Microsoft Steady In Post-Session

    IBD
  22. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  23. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  24. Oil Dominates; Keurig, Constellation Near Buy Points

    IBD
  25. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  26. Biogen Shares Rebound As Street Has A Change Of Heart

    IBD
  27. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  28. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  29. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  30. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD
  31. IBD Big Cap 20 Leaders Hold Up Well Despite Shaky Market

    IBD
  32. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD
  33. Stocks Close Higher As Biotech, Internet Stocks Gain

    IBD
  34. Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds Slightly

    Benzinga
  35. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  36. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  37. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
  38. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  39. AbbVie, Shire Give Bullish Guidance Amid Buyout Talk

    IBD
  40. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga
  41. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  42. Biogen, AbbVie Report Positive Top-Line Results from Phase 3 Trial of Daclizumaba ...

    Benzinga
  43. 50-Day Moving Average Can Buffer A Strong Stock's Advance

    IBD
  44. UPDATE: Morgan Stanley Reiterates On Biogen Idec As Positive RPC1063 Data ...

    Benzinga
  45. Stock Indexes Slightly Up; Apple Split Takes Effect

    IBD
  46. UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Good News On ...

    Benzinga
  47. US Stock Futures Slightly Lower Ahead Of McDonald's Sales Report

    Benzinga
  48. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  49. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  50. Investor's Corner: How To Use The Big Cap 20

    IBD
Trading Center